retatrutide clinical trial results 2024 2025 press release eli lilly may become one of the most important longevity-related Summary of the highest percent

Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor

While effective for glycemic control and weight management, these mechanisms can limit nutrient intake and affect absorption

Tens of thousands of people have swapped their supplement routine for patches and they're not going back

At Set Point Medical Weight Loss Clinic, most patients begin noticing a reduction in appetite within the first few weeks, particularly as the dosage increases

In a study of Rybelsus (the earlier formulation of the Ozempic pill, also with all participants eating a standardized breakfast), people reported fewer cravings and better control over their eating by the three-month mark